Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma

Ziwei Yu, Paul M. Weinberger, Bruce Haffty, Clarence Sasaki, Cynthia Zerillo, John Joe, Diane Kowalski, James Dziura, Robert L. Camp, David L. Rimm, Amanda Psyrri

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Background: The current tumor-node-metastasis system is inadequate to accurately classify patients in terms of prognosis. Thus, with the availability of recently developed molecular tools, considerable interest lies in discovering prognostic markers in order to guide treatment decisions. In this study, we sought to determine the prognostic significance of the cell cycle regulator cyclin D1 in oropharyngeal squamous cell carcinoma (OSCC). Experimental Design: We studied the protein expression levels of cyclin D1 on a tissue microarray composed of 63 OSCCs with long-term follow-up data available. Protein expression was analyzed with an automated in situ quantitative (AQUA) method which allows preservation of tissue morphology while quantifying protein expression in paraffin-embedded tissue. Results: The mean follow-up time was 35 months. High cyclin D1 nuclear expression was associated with increased 5-year local recurrence rate (48% versus 15%), inferior 5-year disease-free survival (16% versus 58%), and inferior 5-year overall survival (17% versus 53%). In multivariate Cox regression, high nuclear cyclin D1 expression was an independent predictor for local recurrence, disease-free survival, and overall survival at 5 years. Conclusions: Our results indicate that quantitative assessment of nuclear cyclin D1 expression level by automated in situ quantitative analysis is a strong predictor for outcome in OSCC. Thus, cyclin D1 may be a potential target for molecular intervention in patients with oropharyngeal squamous cell cancer.

Original languageEnglish (US)
Pages (from-to)1160-1166
Number of pages7
JournalClinical Cancer Research
Volume11
Issue number3
StatePublished - Feb 1 2005

Fingerprint

Cyclin D1
Squamous Cell Carcinoma
Disease-Free Survival
Tissue Preservation
Oropharyngeal Neoplasms
Recurrence
Squamous Cell Neoplasms
Proteins
Survival
Paraffin
Cell Cycle
Research Design
Neoplasm Metastasis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Yu, Z., Weinberger, P. M., Haffty, B., Sasaki, C., Zerillo, C., Joe, J., ... Psyrri, A. (2005). Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clinical Cancer Research, 11(3), 1160-1166.
Yu, Ziwei ; Weinberger, Paul M. ; Haffty, Bruce ; Sasaki, Clarence ; Zerillo, Cynthia ; Joe, John ; Kowalski, Diane ; Dziura, James ; Camp, Robert L. ; Rimm, David L. ; Psyrri, Amanda. / Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 3. pp. 1160-1166.
@article{8d9a9223cef1494aaf3dbb2bd15992a3,
title = "Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma",
abstract = "Background: The current tumor-node-metastasis system is inadequate to accurately classify patients in terms of prognosis. Thus, with the availability of recently developed molecular tools, considerable interest lies in discovering prognostic markers in order to guide treatment decisions. In this study, we sought to determine the prognostic significance of the cell cycle regulator cyclin D1 in oropharyngeal squamous cell carcinoma (OSCC). Experimental Design: We studied the protein expression levels of cyclin D1 on a tissue microarray composed of 63 OSCCs with long-term follow-up data available. Protein expression was analyzed with an automated in situ quantitative (AQUA) method which allows preservation of tissue morphology while quantifying protein expression in paraffin-embedded tissue. Results: The mean follow-up time was 35 months. High cyclin D1 nuclear expression was associated with increased 5-year local recurrence rate (48{\%} versus 15{\%}), inferior 5-year disease-free survival (16{\%} versus 58{\%}), and inferior 5-year overall survival (17{\%} versus 53{\%}). In multivariate Cox regression, high nuclear cyclin D1 expression was an independent predictor for local recurrence, disease-free survival, and overall survival at 5 years. Conclusions: Our results indicate that quantitative assessment of nuclear cyclin D1 expression level by automated in situ quantitative analysis is a strong predictor for outcome in OSCC. Thus, cyclin D1 may be a potential target for molecular intervention in patients with oropharyngeal squamous cell cancer.",
author = "Ziwei Yu and Weinberger, {Paul M.} and Bruce Haffty and Clarence Sasaki and Cynthia Zerillo and John Joe and Diane Kowalski and James Dziura and Camp, {Robert L.} and Rimm, {David L.} and Amanda Psyrri",
year = "2005",
month = "2",
day = "1",
language = "English (US)",
volume = "11",
pages = "1160--1166",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

Yu, Z, Weinberger, PM, Haffty, B, Sasaki, C, Zerillo, C, Joe, J, Kowalski, D, Dziura, J, Camp, RL, Rimm, DL & Psyrri, A 2005, 'Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma', Clinical Cancer Research, vol. 11, no. 3, pp. 1160-1166.

Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. / Yu, Ziwei; Weinberger, Paul M.; Haffty, Bruce; Sasaki, Clarence; Zerillo, Cynthia; Joe, John; Kowalski, Diane; Dziura, James; Camp, Robert L.; Rimm, David L.; Psyrri, Amanda.

In: Clinical Cancer Research, Vol. 11, No. 3, 01.02.2005, p. 1160-1166.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma

AU - Yu, Ziwei

AU - Weinberger, Paul M.

AU - Haffty, Bruce

AU - Sasaki, Clarence

AU - Zerillo, Cynthia

AU - Joe, John

AU - Kowalski, Diane

AU - Dziura, James

AU - Camp, Robert L.

AU - Rimm, David L.

AU - Psyrri, Amanda

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Background: The current tumor-node-metastasis system is inadequate to accurately classify patients in terms of prognosis. Thus, with the availability of recently developed molecular tools, considerable interest lies in discovering prognostic markers in order to guide treatment decisions. In this study, we sought to determine the prognostic significance of the cell cycle regulator cyclin D1 in oropharyngeal squamous cell carcinoma (OSCC). Experimental Design: We studied the protein expression levels of cyclin D1 on a tissue microarray composed of 63 OSCCs with long-term follow-up data available. Protein expression was analyzed with an automated in situ quantitative (AQUA) method which allows preservation of tissue morphology while quantifying protein expression in paraffin-embedded tissue. Results: The mean follow-up time was 35 months. High cyclin D1 nuclear expression was associated with increased 5-year local recurrence rate (48% versus 15%), inferior 5-year disease-free survival (16% versus 58%), and inferior 5-year overall survival (17% versus 53%). In multivariate Cox regression, high nuclear cyclin D1 expression was an independent predictor for local recurrence, disease-free survival, and overall survival at 5 years. Conclusions: Our results indicate that quantitative assessment of nuclear cyclin D1 expression level by automated in situ quantitative analysis is a strong predictor for outcome in OSCC. Thus, cyclin D1 may be a potential target for molecular intervention in patients with oropharyngeal squamous cell cancer.

AB - Background: The current tumor-node-metastasis system is inadequate to accurately classify patients in terms of prognosis. Thus, with the availability of recently developed molecular tools, considerable interest lies in discovering prognostic markers in order to guide treatment decisions. In this study, we sought to determine the prognostic significance of the cell cycle regulator cyclin D1 in oropharyngeal squamous cell carcinoma (OSCC). Experimental Design: We studied the protein expression levels of cyclin D1 on a tissue microarray composed of 63 OSCCs with long-term follow-up data available. Protein expression was analyzed with an automated in situ quantitative (AQUA) method which allows preservation of tissue morphology while quantifying protein expression in paraffin-embedded tissue. Results: The mean follow-up time was 35 months. High cyclin D1 nuclear expression was associated with increased 5-year local recurrence rate (48% versus 15%), inferior 5-year disease-free survival (16% versus 58%), and inferior 5-year overall survival (17% versus 53%). In multivariate Cox regression, high nuclear cyclin D1 expression was an independent predictor for local recurrence, disease-free survival, and overall survival at 5 years. Conclusions: Our results indicate that quantitative assessment of nuclear cyclin D1 expression level by automated in situ quantitative analysis is a strong predictor for outcome in OSCC. Thus, cyclin D1 may be a potential target for molecular intervention in patients with oropharyngeal squamous cell cancer.

UR - http://www.scopus.com/inward/record.url?scp=19944432059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944432059&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 1160

EP - 1166

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 3

ER -

Yu Z, Weinberger PM, Haffty B, Sasaki C, Zerillo C, Joe J et al. Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clinical Cancer Research. 2005 Feb 1;11(3):1160-1166.